Chetan T. Goudar is an Executive Director of Process Development at Amgen. His team is responsible for developing Drug Substance processes for all molecules in Amgen’s polymodal late-stage pipeline and enabling progression of these assets to commercial licensure. His team is also engaged in advancing drug substance manufacturing through the application of continuous principles across both synthetic and biologic modalities. Prior to joining Amgen in 2012, Chetan spent 13 years at Bayer HealthCare’s Process Development group in Berkeley. He is a recipient of the ACS BIOT and the Biochemical Engineering Journal Young Investigator awards in 2014 and has a Ph.D. in Chemical & Biological Engineering from the University of British Columbia.
Chetan T. Goudar
Executive Director of Process Development